AND EXCHANGE COMMISSION
to Section 13 OR 15(d) of the
Exchange Act of 1934
of Report (Date of earliest event reported): March 25, 2020 (March 25, 2020)
name of registrant as specified in its charter)
or other jurisdiction
Lincoln Road, 4th Floor
of Principal Executive Offices)
telephone number: (305) 907-7600
name or former address, if changed since last report)
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
registered pursuant to Section 12(b) of the Act: None.
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
growth company [ ]
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Labs, Inc. (the “Company”) will be relying on the Securities and Exchange Commission’s Order under Section 36
of the Securities Exchange Act of 1934 Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder
dated March 4, 2020 (Release No. 34-88318) (the “Order”) to delay the filing of its Annual Report on Form 10-K for
the year ended December 31, 2019 (the “Report”) due to the circumstances related to COVID-19. In particular, COVID-19
has caused severe disruptions in transportation and limited access to the Company’s facilities resulting in limited support
from its staff and professional advisors. This has, in turn, delayed the Company’s ability to complete its audit and prepare
the Report. Notwithstanding the foregoing, the Company expects to file the Report no later than May 14, 2020 (which is 45 days
from the Report’s original filing deadline of March 30, 2020).
light of the current COVID-19 pandemic, the Company will be including the following Risk Factor into its Report:
occurrence of an uncontrollable event such as the COVID-19 pandemic is likely to negatively affect our operations.
occurrence of an uncontrollable event such as the COVID-19 pandemic is likely to negatively affect our operations. A pandemic
typically results in social distancing, travel bans and quarantine, and this has limited access to our facilities, customers,
management, support staff and professional advisors. These, in turn, will not only impact our operations, financial condition
and demand for our services but our overall ability to react timely to mitigate the impact of this event. Also, it may
substantially hamper our efforts to provide our investors with timely information and comply with our filing obligations with
the Securities and Exchange Commission.
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
||Balance Labs, Inc. |
March 26, 2020
|/s/ Michael D. Farkas|